Search Results

There are 938 results for: content related to: Safety and efficacy of oral fexofenadine in children with seasonal allergic rhinitis – a pooled analysis of three studies

  1. Enantioselective uptake of fexofenadine by Caco-2 cells as model intestinal epithelial cells

    Journal of Pharmacy and Pharmacology

    Volume 65, Issue 1, January 2013, Pages: 22–29, Kohei Togami, Yuka Tosaki, Sumio Chono, Kazuhiro Morimoto, Masataka Hayasaka and Hitoshi Tada

    Article first published online : 25 OCT 2012, DOI: 10.1111/j.2042-7158.2012.01569.x

  2. You have free access to this content
    The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers

    British Journal of Clinical Pharmacology

    Volume 65, Issue 5, May 2008, Pages: 693–700, Tomonori Tateishi, Masatomo Miura, Toshio Suzuki and Tsukasa Uno

    Article first published online : 20 FEB 2008, DOI: 10.1111/j.1365-2125.2008.03116.x

  3. The systemic safety of fexofenadine HCl

    Clinical & Experimental Allergy

    Volume 29, Issue S3, July 1999, Pages: 163–170, J. Mason, R. Reynolds and N. Rao

    Article first published online : 10 SEP 2009, DOI: 10.1046/j.1365-2222.1999.0290s3163.x

  4. H1-antihistamines for chronic spontaneous urticaria

    Intervention Review

    The Cochrane Library

    Maulina Sharma, Cathy Bennett, Stuart N Cohen and Ben Carter

    Published Online : 14 NOV 2014, DOI: 10.1002/14651858.CD006137.pub2

  5. Time-Dependent Interaction Between Lopinavir/Ritonavir and Fexofenadine

    The Journal of Clinical Pharmacology

    Volume 46, Issue 7, July 2006, Pages: 758–767, P. G. Rolf, Dr van Heeswijk, Mr Marc Bourbeau, Ms Pearl Campbell, Ms Isabelle Seguin, Mr Bobby M. Chauhan, Dr Brian C. Foster and Dr D. William Cameron

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270006288733

  6. Evaluation of First-Pass Cytochrome P4503A (CYP3A) and P-Glycoprotein Activities Using Alfentanil and Fexofenadine in Combination

    The Journal of Clinical Pharmacology

    Volume 45, Issue 1, January 2005, Pages: 79–88, Dr Evan D. Kharasch, Ms Alysa Walker, Ms Christine Hoffer and Ms Pamela Sheffels

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270004269705

  7. Multiple transport mechanisms involved in the intestinal absorption and first-pass extraction of fexofenadine

    Clinical Pharmacology & Therapeutics

    Volume 74, Issue 5, November 2003, Pages: 423–436, Christer Tannergren, Niclas Petri, Lars Knutson, Mikael Hedeland, Ulf Bondesson and Hans Lennernäs

    Article first published online : 27 NOV 2003, DOI: 10.1016/S0009-9236(03)00238-8

  8. Effect of Grapefruit Juice Volume on the Reduction of Fexofenadine Bioavailability: Possible Role of Organic Anion Transporting Polypeptides

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 3, March 2005, Pages: 170–177, George K. Dresser, Richard B. Kim and David G. Bailey

    Article first published online : 7 MAR 2005, DOI: 10.1016/j.clpt.2004.10.005

  9. You have free access to this content
    Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil

    British Journal of Clinical Pharmacology

    Volume 67, Issue 5, May 2009, Pages: 535–540, Takashi Sakugawa, Masatomo Miura, Nobuo Hokama, Toshio Suzuki, Tomonori Tateishi and Tsukasa Uno

    Article first published online : 23 FEB 2009, DOI: 10.1111/j.1365-2125.2009.03396.x

  10. You have free access to this content
    Effects of multiple-dose rifampicin 450 mg on the pharmacokinetics of fexofenadine enantiomers in Japanese volunteers

    Journal of Clinical Pharmacy and Therapeutics

    Volume 40, Issue 1, February 2015, Pages: 98–103, Y. Akamine, M. Miura, N. Yasui-Furukori, I. Ieiri and T. Uno

    Article first published online : 27 SEP 2014, DOI: 10.1111/jcpt.12213

  11. Probenecid, but Not Cystic Fibrosis, Alters the Total and Renal Clearance of Fexofenadine

    The Journal of Clinical Pharmacology

    Volume 48, Issue 8, August 2008, Pages: 957–965, Dr. Shanshan Liu, Paul M. Beringer, Dr. Levita Hidayat, Dr. Adupa P. Rao, Dr. Stan Louie, Dr. Gilbert J. Burckart and Dr. Bertrand Shapiro

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008319707

  12. The effect of rifampin administration on the disposition of fexofenadine

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 3, March 2001, Pages: 114–121, Mitchell A. Hamman, Melissa A. Bruce, Barbara D. Haehner-Daniels and Stephen D. Hall

    Article first published online : 18 MAR 2001, DOI: 10.1067/mcp.2001.113697

  13. The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substrates

    Clinical Pharmacology & Therapeutics

    Volume 79, Issue 3, March 2006, Pages: 218–230, Girum L. Lemma, Zaiqi Wang, Mitchell A. Hamman, Narjis A. Zaheer, J. Christopher Gorski and Stephen D. Hall

    Article first published online : 7 FEB 2006, DOI: 10.1016/j.clpt.2005.11.001

  14. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 29, Issue 2, April 2006, Pages: 129–135, L. OLSÉN, C. INGVAST-LARSSON, P. LARSSON, H. BROSTRÖM, U. BONDESSON, M. SUNDQVIST and H. TJÄLVE

    Article first published online : 1 MAR 2006, DOI: 10.1111/j.1365-2885.2006.00724.x

  15. You have free access to this content
    Effects of itraconazole and diltiazem on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein

    British Journal of Clinical Pharmacology

    Volume 61, Issue 5, May 2006, Pages: 538–544, Mikiko Shimizu, Tsukasa Uno, Kazunobu Sugawara and Tomonori Tateishi

    Article first published online : 27 FEB 2006, DOI: 10.1111/j.1365-2125.2006.02613.x

  16. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of fexofenadine in relation to the MDR1 genetic polymorphism

    Clinical Pharmacology & Therapeutics

    Volume 78, Issue 2, August 2005, Pages: 191–201, Ji-Hong Shon, Young-Ran Yoon, Won-Seok Hong, Phuc Minh Nguyen, Sang-Seop Lee, Young-Gil Choi, In-Jun Cha and Jae-Gook Shin

    Article first published online : 11 AUG 2005, DOI: 10.1016/j.clpt.2005.04.012

  17. Different Effects of Three Transporting Inhibitors, Verapamil, Cimetidine, and Probenecid, on Fexofenadine Pharmacokinetics

    Clinical Pharmacology & Therapeutics

    Volume 77, Issue 1, January 2005, Pages: 17–23, Norio Yasui-Furukori, Tsukasa Uno, Kazunobu Sugawara and Tomonori Tateishi

    Article first published online : 16 JAN 2005, DOI: 10.1016/j.clpt.2004.08.026

  18. Effect of Piperine, a Major Component of Black Pepper, on the Intestinal Absorption of Fexofenadine and Its Implication on Food–Drug Interaction

    Journal of Food Science

    Volume 75, Issue 3, April 2010, Pages: H93–H96, Ming-Ji Jin and Hyo-Kyung Han

    Article first published online : 11 MAR 2010, DOI: 10.1111/j.1750-3841.2010.01542.x

  19. Naringin is a Major and Selective Clinical Inhibitor of Organic Anion-Transporting Polypeptide 1A2 (OATP1A2) in Grapefruit Juice

    Clinical Pharmacology & Therapeutics

    Volume 81, Issue 4, April 2007, Pages: 495–502, D G Bailey, G K Dresser, B F Leake and R B Kim

    Article first published online : 14 FEB 2007, DOI: 10.1038/sj.clpt.6100104

  20. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study

    British Journal of Dermatology

    Volume 148, Issue 6, June 2003, Pages: 1212–1221, M. Kawashima, T. Tango, T. Noguchi, M. Inagi, H. Nakagawa and S. Harada

    Article first published online : 27 JUN 2003, DOI: 10.1046/j.1365-2133.2003.05293.x